SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-24-007939
Filing Date
2024-01-30
Accepted
2024-01-30 16:19:12
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea192382-f3_scinaiimmun.htm F-3 441421
2 OPINION OF GOLDFARB GROSS SELIGMAN & CO., ISRAELI COUNSEL TO THE COMPANY RE LEGA ea192382ex5-1_scinaiimmun.htm EX-5.1 7722
3 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ea192382ex23-1_scinaiimmun.htm EX-23.1 2497
4 FILING FEE TABLE ea192382ex-fee_scinaiimmun.htm EX-FILING FEES 25176
5 GRAPHIC image_001.jpg GRAPHIC 5362
6 GRAPHIC image_002.jpg GRAPHIC 5362
7 GRAPHIC ex5-1_001.jpg GRAPHIC 11476
8 GRAPHIC ex5-1_002.jpg GRAPHIC 12872
  Complete submission text file 0001213900-24-007939.txt   526894
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-276767 | Film No.: 24578424
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)